Virtual Medicinal Product (VMP) - Levodopa 20mg/ml / Carbidopa monohydrate 5mg/ml intestinal gel 100ml cassette
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Levodopa 20mg/ml / Carbidopa monohydrate 5mg/ml intestinal gel 100ml cassette | Start Date 11-12-2024 | End Date |
| Previous Name | Previous Name Co-careldopa 5mg/20mg/1ml intestinal gel 100ml cassette | Start Date 09-03-2006 |
End Date
|
| Abbreviated Name | Abbreviated Name Levodopa 20mg/ml/Carbidopa monohydrate 5mg/ml intestinal gel | Start Date 11-12-2024 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- cassette
- Unit Dose UOM
- cassette
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intestinal
- Form
- Intestinal gel
- Ontology Form/Route
- intestinalgel.intestinal
- Name Basis
- Other
Codes
- ATC Code
- N04BA02
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 04090100 | Start Date 04-04-2022 | End Date |
| Previous BNF 04090100 | Start Date 11-05-2006 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 10161711000001105 | 09-03-2006 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Carbidopa monohydrate | Based on Ingredient Substance | 5 mg | 1 ml | |
| Levodopa | Based on Ingredient Substance | 20 mg | 1 ml |
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Name
Carbidopa monohydrate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-careldopa
-
VMP(Current) Levodopa 20mg/ml / Carbidopa monohyd...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 cassette | ||
| 7 cassette |